Patent Application
Provisional
App. No. 63/508,789
· Confirmation No. 6652
METHODS OF TREATING SKELETAL DYSPLASIAS
Inventors:
Riccardo Panicucci, Susan Arangio, Carl Dambkowski, Michael Henderson, Daniela Rogoff, Michael Monteith, Lihua Zhang
Applicant:
QED Therapeutics, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-07-03 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2023-06-16 | SPEC |
Specification | — | View | |
| 2023-06-16 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2023-06-16 | TR.PROV |
Provisional Cover Sheet (SB16) | 4 | View | |
| 2023-06-16 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2023-06-16 | SPEC |
Specification | 89 | View | |
| 2023-06-16 | CLM |
Claims | 8 | View | |
| 2023-06-16 | ABST |
Abstract | 1 | View | |
| 2023-06-16 | DRW.NONBW |
Drawings-other than black and white line drawings | 15 | View | |
| 2023-06-16 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2023-06-16 | ADS |
Application Data Sheet | 10 | View | |
| 2023-06-16 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View |
Inventors
Riccardo Panicucci
Bluffton, SC
Susan Arangio
Los Altos, CA
Carl Dambkowski
San Mateo, CA
Michael Henderson
San Francisco, CA
Daniela Rogoff
Mountain View, CA
Michael Monteith
Raleigh, NC
Lihua Zhang
Cary, NC
Attorneys & Agents of Record
Prosecution
- Customer No.
- 51414
- Docket No.
- QED-010PR2
- Confirmation No.
- 6652
BRIDGEBIO PHARMA, INC.,
QED THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
CALCILYTIX THERAPEUTICS INC.,
ADRENAS THERAPEUTICS INC.,
PHOENIX TISSUE REPAIR, INC.,
NAVIRE PHARMA, INC.,
VENTHERA, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
PORTAL THERAPEUTICS, INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
FERRO THERAPEUTICS, INC.
RELEASE OF SECURITY INTEREST IN PATENT COLLATERAL
Recorded 2025-03-05
from
HENDERSON, MICHAEL
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-05-06
from
ARANGIO, SUSAN,
PANICUCCI, RICCARDO,
ZHANG, LIHUA,
MONTEITH, MICHAEL,
DAMBKOWSKI, CARL,
ROGOFF, DANIELA
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-05-06
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2024-05-06
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
BRIDGEBIO PHARMA, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
EIDOS THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
ML BIO SOLUTIONS INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
QED THERAPEUTICS, INC.,
SUB21, INC.,
THERAS, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-19
from
ADRENAS THERAPEUTICS INC.,
BRIDGEBIO GENE THERAPY RESEARCH, INC.,
CALCILYTIX THERAPEUTICS INC.,
CANTERO THERAPEUTICS, INC.,
COA THERAPEUTICS, INC.,
FERRO THERAPEUTICS, INC.,
MOLECULAR SKIN THERAPEUTICS, INC.,
NAVIRE PHARMA, INC.,
PHOENIX TISSUE REPAIR, INC.,
PORTAL THERAPEUTICS, INC.,
SUB21, INC.,
VENTHERA, INC.
SECURITY INTEREST
Recorded 2024-01-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/508,789
- Filed
- 2023-06-16
External Links